Precisemab Overview
- Year Founded
-
2011
- Status
-
Private
- Employees
-
5
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
3
Precisemab General Information
Description
Developer of antibody technology intended for the safety of antibody drugs via our universal antibody lock technology. The company offers universal antibody lock mechanisms, enhanced selectivity features, and optimized structural configurations applicable to monoclonal antibodies, anti-drug antibodies, and bispecific antibodies, enabling healthcare professionals to give patients the safest possible therapy.
Contact Information
Website
www.precisemab.com.twCorporate Office
- 17th Floor, No. 3, Yuanqu Street
- Nangang District
- Taipei City
- Taiwan
Corporate Office
- 17th Floor, No. 3, Yuanqu Street
- Nangang District
- Taipei City
- Taiwan
Precisemab Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Accelerator/Incubator | 28-Feb-2024 | Completed | Generating Revenue | |||
| 3. Early Stage VC | 29-Jul-2022 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 01-Jan-2021 | Completed | Generating Revenue | |||
| 1. Grant | 30-Nov-2019 | $2M | Completed | Generating Revenue |
Precisemab Patents
Precisemab Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026184705-A1 | Conditionally activated lock-anti-egfr antibody for cancer therapy | Pending | 07-Mar-2025 |
Precisemab Signals
Precisemab Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Paragon Investment | Venture Capital | Minority | ||
| Taiwan Phoenix | Accelerator/Incubator | Minority | ||
| Stpi | Corporation | Minority |
Precisemab FAQs
-
When was Precisemab founded?
Precisemab was founded in 2011.
-
Where is Precisemab headquartered?
Precisemab is headquartered in Taipei City, Taiwan.
-
What is the size of Precisemab?
Precisemab has 5 total employees.
-
What industry is Precisemab in?
Precisemab’s primary industry is Drug Discovery.
-
Is Precisemab a private or public company?
Precisemab is a Private company.
-
What is Precisemab’s current revenue?
The current revenue for Precisemab is .
-
How much funding has Precisemab raised over time?
Precisemab has raised $1.6M.
-
Who are Precisemab’s investors?
Paragon Investment, Taiwan Phoenix, and Stpi have invested in Precisemab.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process